Trial Profile
The Effect of Tigecycline on Diabetic Foot Infections: Prospective Observational Experience of 90 Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Oct 2015
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Skin and soft tissue infections
- Focus Therapeutic Use
- 29 Oct 2015 New trial record
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.